Atlas Trials

TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19

Clinical trial NCT04967430 · UNKNOWN

Trial details

NCT number
NCT04967430
Sponsor
University Health Network, Toronto
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Sars-CoV2Covid19
Start date
2021-08-27
Primary completion
2022-03-21
Enrollment
763

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.